Elucidating the Therapeutic Potential of Potentilla nivea L. for Rheumatoid Arthritis Through Network Pharmacology, Molecular Docking, and Experimental Validation
Chemistry & Biodiversity · 2026-03 · 23 (3)
DOI: 10.1002/cbdv.202503259 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, online erschienen am 04.03.2026. Verfasst von Xun Yan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Research Center for Traditional Chinese Medicine Resources and Ethnic Minority Medicine, Jiangxi University of Chinese Medicine, Nanchang, China. Hauptthemen laut MEDLINE: Potentilla, Network Pharmacology, Arthritis, Rheumatoid, Molecular Docking Simulation. Die Arbeit nennt 28 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangxi Province, Inherited and Innovative Group of Processing Technique of Traditional Chinese Medicine.
Abstract (Originalsprache)
This study explored the molecular mechanism of Potentilla nivea in treating rheumatoid arthritis (RA) using network pharmacology (NP) and experimental validation. In a collagen‐induced arthritis (CIA) rat model, treatment with ethanol extract of P. nivea (PN) significantly attenuated joint swelling, reduced arthritis scores, and decreased serum levels of pro‐inflammatory cytokines (TNF‐ α , IL‐1 β , IL‐6). NP predictions identified 107 RA‐associated targets across 18 bioactive PN components, with TNF and IL‐6 emerging as hub targets through protein‐protein interaction (PPI) analysis. Functional enrichment analysis revealed that these targets were associated with apoptosis, oxidative stress, and inflammatory pathways, which were further experimentally validated in RAW264.7 cells. Specifically, PN mitigated hydrogen peroxide‐induced apoptosis, ROS production, and LDH release while inhibiting the cleaved‐caspase‐3, cleaved‐PARP, BAX, and BAD proteins. In addition, PN increased levels of p‐AMPK, SIRT1, and SIRT3. These findings suggest that P. nivea has a strong therapeutic effect against RA, likely due to its regulation of levels of TNF‐ α , IL‐6, IL‐1 β , and the AMPK pathway mediated by SIRT. This work provided valuable insights and evidence for understanding the molecular mechanism of P. nivea on RA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Center for Traditional Chinese Medicine Resources and Ethnic Minority Medicine, Jiangxi University of Chinese Medicine, Nanchang, China.
- Institute of Integrated Chinese and Western Medicine, Nanchang Medical College, Nanchang, China.
- Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
- Department of Critical Care Medicine, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangxi Province
- Inherited and Innovative Group of Processing Technique of Traditional Chinese Medicine
Zitieren
APA
Yan, X., Wu, Q., Pan, B., Gao, Y., Ruan, Z., & Zhong, L. (2026). Elucidating the Therapeutic Potential of Potentilla nivea L. for Rheumatoid Arthritis Through Network Pharmacology, Molecular Docking, and Experimental Validation. Chemistry & Biodiversity, 23(3). https://doi.org/10.1002/cbdv.202503259
Vancouver
Yan X, Wu Q, Pan B, Gao Y, Ruan Z, Zhong L. Elucidating the Therapeutic Potential of Potentilla nivea L. for Rheumatoid Arthritis Through Network Pharmacology, Molecular Docking, and Experimental Validation. Chemistry & Biodiversity. 2026;23(3). doi:10.1002/cbdv.202503259
BibTeX
@article{Yan2026,
author = {Yan, Xun and Wu, Qiang and Pan, Bingfa and Gao, Yanping and Ruan, Zhengshang and Zhong, Lingyun},
title = {Elucidating the Therapeutic Potential of Potentilla nivea L. for Rheumatoid Arthritis Through Network Pharmacology, Molecular Docking, and Experimental Validation},
journal = {Chemistry & Biodiversity},
year = {2026},
volume = {23},
number = {3},
doi = {10.1002/cbdv.202503259}
}
EUVIMED